Peripheral neuropathy decisions — 2026

The Board has restored service connection for Type II diabetes mellitus and granted service connection for various peripheral neuropathies and a heart disability, all related to the Veteran's exposure to contaminated C-123 aircraft during his military service.

The Veteran's diabetes mellitus type 2 is presumed to be related to herbicide agent exposure in service. The Board granted service connection for right upper extremity and bilateral lower extremity neuropathy as secondary to the service-connected diabetes.

The Board has denied service connection for peripheral neuropathy of the right and left upper extremities due to a lack of current evidence of these conditions.

The Board has remanded the Veteran's claims for increased ratings for his bilateral lower extremity neuropathy due to scheduling issues and lack of examination. The case is also remanded for a TDIU determination.

The Board has decided to remand the Veteran's claims for right and left lower extremity sciatic nerve peripheral neuropathy due to a lack of adequate medical examination, specifically regarding the effects of prescribed medication.

The Veteran is granted special monthly compensation at the intermediate rate between 38 U.S.C. § 1114 subsections (n) and (o) due to multiple service-connected disabilities independently rated at 50 percent or more.

The Board has remanded the case due to inadequate examination and failure to consider lay statements. The Veteran is seeking service connection for ulnar neuropathy in his right hand, which he claims developed during service.

The Board has granted the Veteran's claim for service connection for multifocal motor neuropathy of all extremities, finding that her symptoms have been continuous since her period of active service and supported by a positive VA opinion.

The Board has dismissed the appeals for service connection of various disabilities due to the Veteran's death during the appeal process.

The Veteran's bilateral lower extremity diabetic neuropathy is rated at 20 percent, effective June 24, 2015.

The Board has remanded the Veteran's claims for service connection due to insufficient medical opinions regarding the relationship between his diabetes mellitus and his claimed conditions. The issues are inextricably intertwined with the outcome of the diabetes claim.

The Veteran's voiding dysfunction is granted as secondary to his service-connected type II diabetes mellitus.,Increased ratings of 20 percent are granted for left and right upper extremity peripheral neuropathy, with separate 10 percent ratings granted for left and right lower extremity peripheral neuropathy. Separate 10 percent ratings are also granted for left and right lower extremity femoral peripheral neuropathy.

The Veteran's claim for a compensable rating for pseudofolliculitis barbae with scarring prior to February 7, 2025 is denied. The evidence does not meet the criteria for a compensable rating under the applicable VA rating schedule.,Service connection for diabetes mellitus, kidney failure and urinary frequency, bilateral lower extremity peripheral neuropathy, obstructive sleep apnea, and vertigo are all denied. There is no credible evidence linking these conditions to service or any presumptive exposure basis.

The Veteran's bilateral upper and lower extremity diabetic neuropathy causes the loss of use of his hands and feet, warranting special monthly compensation (SMC). The Board finds there is an approximate balance of positive and negative evidence as to whether the Veteran's condition meets the criteria for SMC based on loss of use of feet and hands.

The Board has remanded the Veteran's claims for erectile dysfunction, obstructive sleep apnea, and peripheral neuropathy of the right foot and left leg due to duty-to-assist errors in prior opinions.

The Veteran's service-connected disabilities, including hypertension and other conditions, rendered him unable to secure or follow substantially gainful employment from April 14, 2021, until May 22, 2024. The Board granted a total disability rating based on individual unemployability during this period.

The Board has dismissed the Veteran's appeals for service connection on all four issues due to the RO's deferred decisions not constituting final adjudicative determinations.

The Board has granted service connection for prostate cancer and diabetes mellitus, type 2 effective August 10, 2022 based on the PACT Act presumption of herbicide exposure. The claims for colon cancer, peripheral neuropathy of the left lower extremity, and peripheral neuropathy of the right lower extremity are remanded due to inadequate development.

The Veteran's claims for a compensable initial rating and effective dates for service connection are being remanded due to the need to obtain additional VA treatment records from Denver, Colorado, and private treatment records that have been scanned into VistA Imaging.

The Board has denied the Veteran's claims for service connection for diabetes mellitus type II, hypertension, kidney end stage renal failure, peripheral neuropathy of the right and left lower extremities, and alveolar hydatid disease due to a lack of evidence linking these conditions to his military service.